Veröffentlichungen

Die QSM-Bildgebungstechnologie ist Gegenstand von mehr als 3000 wissenschaftlichen Veröffentlichungen. Eine Auswahl von Referenzen:

How and why implement ISO27001?

How and why implement ISO27001? Committed to a quality approach involving information security manag…

Stephane Roche becomes CEO of Ventio

Stephane Roche becomes CEO of Ventio Technical Director for the past 2 years, Dr Stephane Roche took…

Welche Mechanismen setzt Ventio ein um die Qualität und Sicherheit seiner Cloud- und biomedizinischen Bildverarbeitungsdienste zu gewährleisten? 

Welche Mechanismen setzt Ventio ein um die Sicherheit seiner Cloud und biomedizinischen Bilddatenver…

QSM Quantitative Susceptibility Mapping

Dr. Stephane ROCHE, PhD, Dr. Ludovic de ROCHEFORT, PhD; November 2022 Definition: QSM (Quantitative …

QMR Lucca 2022

QSM4SENIOR: Quantitative susceptibility mapping in the aging of the healthy brain. Miguel Guevara1,2…

QSM as an imaging biomarker for Alzheimer’s disease

Quantitative susceptibility mapping as an imaging biomarker for Alzheimer’s disease: The expectation…

How does QSM perform in detecting this process?

Brain pathological changes during neurodegenerative diseases and their identification methods: How d…

sAPP & Abeta in CSF

Correlations between soluble alpha/beta forms of amyloid precursor protein and Abeta38, 40 and 42 in…

FDA-clearance

510(k) Premarket Notification Device Classification Name system, nuclear magnetic resonance imaging …

QSM Patent

Accurate quantification of magnetic susceptibility in molecular mri Inventor: Yi Wang, Ludovic De Ro…

SENIOR cohort : Imaging the aging brain

Imaging the aging brain: study design and baseline findings of the SENIOR cohort Alexa Haeger, Jean-…

Clinical Integration of QSM into Neurosurgical Practice

Clinical Integration of Quantitative Susceptibility Mapping Magnetic Resonance Imaging into Neurosur…

Clinical Integration of Automated Processing for Brain QSM

Clinical Integration of Automated Processing for Brain Quantitative Susceptibility Mapping: Multi-Si…

APP Ab38 Ab40 in FTD

Decreased sAβPPβ, Aβ38, and Aβ40 Cerebrospinal Fluid Levels in Frontotemporal Dementia Gabelle, Audr…

Quantitative susceptibility map reconstruction

Quantitative susceptibility map reconstruction from MR phase data using bayesian regularization: Val…

Preanalytical guidelines

Preanalytical guidelines for clinical proteomics investigation of biological fluids S Lehmann, S. Ro…

Biomarkers in CSF

Les marqueurs biologiques protéiques du liquide céphalorachidien : caractéristiques et implications …

Autoantibody in CSF

Auto-antibody profiling on high-density protein microarrays for biomarker discovery in the cerebrosp…

Quantitative MR susceptibility mapping

Quantitative MR susceptibility mapping using piece-wise constant regularized inversion of the magnet…

Clinical proteomics in CSF

Clinical proteomics of the cerebrospinal fluid: Towards the discovery of new biomarkers Stéphane Roc…

end of page